Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.

Employees

129

Sector

Advanced Medical Equipment & Technology

More about the company

Quotes

Date	Price	Change	Volume
26/10/26	ILA 3,458.00	0.00%	169,663
23/10/26	ILA 3,458.00	-4.63%	37,436
22/10/26	ILA 3,626.00	-1.25%	42,812
21/10/26	ILA 3,672.00	0.00%	10,794
20/10/26	ILA 3,672.00	-1.26%	29,759

Delayed Quote TEL AVIV STOCK EXCHANGE

More quotes

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - BrainsWay Ltd.

Company calendar

Market Closed - TEL AVIV STOCK EXCHANGE 19:24:49 26/10/2026 +04			5-day change	1st Jan Change
3,458.00 ^ILa	0.00%		-5.83%	+10.66%

10-26	Brainsway Increases Insurance Companies Covering its OCD Treatment	MT
10-19	BrainsWay Ltd. Announces Strategic Collaboration with Inland Psychiatric Medical Group	CI

Market Cap	451M 0 405M 374M 339M 634M 42.87B 642M 4.48B 1.78B 22.47B 1.69B 1.66B 71.26B	P/E 2026 *	-	P/E 2027 *	-
Enterprise Value	451M 0 405M 374M 339M 634M 42.87B 642M 4.48B 1.78B 22.47B 1.69B 1.66B 71.26B	EV / Sales 2026 *	6.53x	EV / Sales 2027 *	5.29x
Free-Float	90.51%	Yield 2026 *	-	Yield 2027 *	-

Markets		Quality
TEL AVIV STOCK EXCHANGE	BWAY	Delayed
OTC Markets	BRSY.F	Delayed

10-26	Brainsway Increases Insurance Companies Covering its OCD Treatment	MT
10-19	BrainsWay Ltd. Announces Strategic Collaboration with Inland Psychiatric Medical Group	CI
10-19	BrainsWay to Supply Deep TMS Systems to Southern California Psychiatric Group	MT
09-21	BrainsWay Ltd.(NasdaqGM:BWAY) dropped from S&P Global BMI Index	CI
09-21	BrainsWay Ltd.(TASE:BWAY) added to S&P Global BMI Index	CI
09-08	Brainsway Reports Promising Pilot Study Results In Patients With Depression And Comorbid Early-Stage Alzheimer's Disease Treated With Deep TMS	CI
09-01	Lifeward Names Josh Hexter as Interim CEO and Rami Aviram as CFO	MT
08-27	BrainsWay Ltd. Publishes Peer-Reviewed Data Demonstrating 70% Reduction in Suicidal Ideation with Deep TMS in Major Depressive Disorder	CI
08-12	BrainsWay Shares Rise After Higher Q2 Results	MT
08-12	BrainsWay Ltd., Q2 2026 Earnings Call, Aug 12, 2026
08-12	BrainsWay Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-12	BrainsWay Ltd. Raises Earnings Guidance for the Fiscal Year 2026	CI
07-20	Radial Health, S.C. announced that it has received $53 million in funding from a group of investors	CI

BrainsWay Ltd. Stock

Stocks

BWAY

IL0011007189

Advanced Medical Equipment & Technology

Valuation: BrainsWay Ltd.

Chart: BrainsWay Ltd.

Latest news: BrainsWay Ltd.

Last Transcript: BrainsWay Ltd.

Analysts' recommendations: BrainsWay Ltd.

Press Releases: BrainsWay Ltd.

Quotes and Performance

Price Extremes

Managers and Directors: BrainsWay Ltd.

Latest insider transactions

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Quotes

Quarterly revenue - Rate of surprise

07-20	BTIG Initiates Brainsway at Buy With $18 Price Target	MT
11-13	BrainsWay Ltd. Receives FDA Clearance of Deep TMS as Adjunct Therapy for Major Depressive Disorder in Adolescents Aged 15 to 21	CI
14/05/25	Oppenheimer Adjusts Brainsway Price Target to $15 From $13, Maintains Outperform Rating	MT
09/05/24	Oppenheimer Adjusts Brainsway Price Target to $11 From $10, Maintains Outperform Rating	MT
09/05/24	HC Wainwright Adjusts Price Target on Brainsway to $15 From $13, Keeps Buy Rating	MT

1 week	-5.83%
Current month	-14.64%
1 month	-13.55%
3 months	-29.96%
6 months	-29.97%
Current year	+10.66%

1 week	3,375	3,669
1 month	3,375	4,090
Current year	3,080	5,165
1 year	2,391	5,165
3 years	652.1	5,165
5 years	272	5,165
10 years	272	5,165

Manager	Title	Age	Since
Hadar Levy CEO	Chief Executive Officer	54	13/02/2023
Yiftach Roth CTO	Chief Tech/Sci/R&D Officer	56	01/05/2006
Ido Marom DFI	Director of Finance/CFO	50	23/05/2023

Director	Title	Age	Since
David Zacut CHM	Chairman	74	01/01/2003
Avner Hagai BRD	Director/Board Member	71	01/11/2006
Abraham Zangen BRD	Director/Board Member	56	17/06/2019

Date	Insider	Type	Main position	Quantity	% Market Cap.
02/06/26	Yiftach Roth	Sell	Founder	-3,000	0.0075%
26/05/26	Eti Mitrany	Sell	Director	-7,980	0.0399%
20/05/26	Eti Mitrany	Exercice	Director	41,080	0.1026%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
BRAINSWAY LTD.	0.00%	-5.83%	+24.25%	+406.44%	451M
THERMO FISHER SCIENTIFIC, INC.	+1.19%	+0.82%	+22.92%	+60.64%	253B
DANAHER CORPORATION	-0.42%	+3.46%	+4.97%	+23.48%	164B
INTUITIVE SURGICAL, INC.	-1.27%	+1.80%	-19.11%	+72.17%	157B
BOSTON SCIENTIFIC CORPORATION	-1.14%	-1.14%	-56.01%	-9.01%	66.06B
VEEVA SYSTEMS INC.	-1.48%	-1.63%	+6.01%	+65.40%	51.52B
SIEMENS HEALTHINEERS AG	-0.99%	+1.04%	-15.38%	-8.70%	52.64B
EDWARDS LIFESCIENCES CORPORATION	+0.29%	+2.87%	+12.37%	+47.17%	52.2B
AGILENT TECHNOLOGIES, INC.	+0.87%	+2.59%	+21.08%	+72.71%	49.61B
WATERS CORPORATION	+2.76%	+5.81%	+33.21%	+91.43%	44.8B
Average	-0.02%	+0.86%	+3.43%	+82.17%	89.1B
Weighted average by Cap.	+0.01%	+1.67%	+2.94%	+48.45%

	2026 *	2027 *
Net sales	69.16M 0 62.07M 57.31M 51.97M 97.13M 6.57B 98.33M 687M 273M 3.44B 260M 254M 10.92B	85.34M 0 76.59M 70.72M 64.13M 120M 8.11B 121M 848M 337M 4.25B 320M 313M 13.47B
Net income	12.38M 0 11.11M 10.26M 9.31M 17.39M 1.18B 17.61M 123M 48.86M 617M 46.48M 45.49M 1.96B	20.96M 0 18.82M 17.37M 15.75M 29.45M 1.99B 29.81M 208M 82.72M 1.04B 78.69M 77.01M 3.31B
Net Debt	-	-